Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000790992 | SCV000930252 | uncertain significance | Cenani-Lenz syndactyly syndrome | 2019-04-27 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000790993 | SCV000930253 | uncertain significance | Congenital myasthenic syndrome 17 | 2019-04-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003258967 | SCV003979884 | uncertain significance | Inborn genetic diseases | 2023-05-05 | criteria provided, single submitter | clinical testing | The c.3346G>A (p.E1116K) alteration is located in exon 24 (coding exon 24) of the LRP4 gene. This alteration results from a G to A substitution at nucleotide position 3346, causing the glutamic acid (E) at amino acid position 1116 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |